The Net Margin of BridgeBio Pharma Inc (BBIO) is -241.44%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -241.44% |
2023-12-31 | -6913.92% |
2022-12-31 | -619.68% |
2021-12-31 | -806.86% |
2020-12-31 | -5439.03% |
2019-12-31 | -642.48% |